Search results
Results from the WOW.Com Content Network
Barnes’ Notes on the Bible says that he was “surnamed Justus” or who “was called Justus”: “This is a Latin name, meaning just, and was probably given him on account of his distinguished integrity.” [citation needed] The Anglican Bible scholar J. B. Lightfoot “supposes that he [Joseph Barsabbas] was the son of Alphaeus and ...
Mometasone, also known as mometasone furoate, is a steroid (specifically, a glucocorticoid) medication used to treat certain skin conditions, hay fever, and asthma. [ 10 ] [ 11 ] [ 12 ] Specifically it is used to prevent rather than treat asthma attacks. [ 10 ]
For treating atopic dermatitis, newer (second generation) corticosteroids, such as fluticasone propionate and mometasone furoate, are more effective and safer than older ones. They are also generally safe and do not cause skin thinning when used intermittently to treat atopic dermatitis flare-ups.
Barsabbas or Barsabas is a surname used in the Acts of the Apostles, to refer to two persons: Joseph called Barsabbas, who was surnamed Justus. He was a candidate to fill the vacancy among the Twelve Apostles. Acts 1:23; Judas Barsabbas, an emissary of the Church of Jerusalem to the Church at Antioch. Acts 15:22; The name denotes either
Mometasone/formoterol, sold under the brand name Dulera among others, is a fixed-dose combination medication used in the long-term treatment of asthma. [1] It contains mometasone a steroid and formoterol a long-acting beta agonist. [1] It is only recommended in those for whom an inhaled steroid is not sufficient. [1] It is used by inhalation. [1]
This drug article relating to the respiratory system is a stub. You can help Wikipedia by expanding it.
It is the first asthma triple-combination therapy; it consists of a fixed-dose combination of three active substances (indacaterol, glycopyrronium bromide and mometasone furoate) in capsules, to be administered using an inhaler. [11] An optional electronic sensor may also be co-packed with the product. [11]
[1] [2] [3] It contains olopatadine hydrochloride and mometasone furoate monohydrate. [1] [2] It is sprayed into the nose. [1] [2] Common side effects include an unpleasant taste . [1] It was approved for medical use in Australia in December 2019, [1] [4] and in the United States in January 2022. [2]